AKT1 and familial pancreatic carcinoma: In the three pancreatic cancer cell lines (BxPC3, AsPC-1 and CFPAC), most BiXAbTM inhibited AKT phosphorylation, except 2Trastu-1Cetu-Fc and 2Trastu-1Matu-Fc (and the structural isomers).